Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Design of reversible, cysteine-targeted Michael acceptors guided by kinetic and computational analysis
Hormone desensitization Any compound that artificially stimulates hormone release carries theoretical risk of desensitization over time
FDA Submission Timeline Based on the TRIUMPH-4 success and expected 2026 readouts, analysts predict: Late 2026: Completion of core TRIUMPH trials Q4 2026 or Q1 2027: New Drug Application (NDA) submission to FDA Mid to Late 2027: Potential FDA approval Early 2028: Commercial launch Eli Lilly has not officially confirmed these timelines, but the company has indicated it will submit for regulatory approval once sufficient Phase 3 data is available
Titration is critical with GLP-1 medications
Its always a good idea to talk to a healthcare provider to see if retatrutide is right for you
US$ 20.19
US$ 22.30
US$ 29.54
US$ 29.48
US$ 28.07
US$ 25.82
